Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q4 | Jan 21, 2026 | TimesSquare Capital Management U.S. Small Cap Growth Strategy | 3.5% | 5.9% | ABVX.PA, AXGN, BOOT, CBLL, CWST, FROG, LGCE, MTSI, NAMS, NSKE, OLLI, SLNO, STVN, TTEK, UEC, WRBY | Biotechnology, consumer, energy, growth, healthcare, industrials, small caps, technology | The fund holds multiple biotech positions including Abivax SA for ulcerative colitis treatment, NewAmsterdam Pharma for cholesterol inhibitors, and Axogen for peripheral nerve regeneration. Strong clinical trial results and FDA approvals are driving performance, with Abivax rising 58% on acquisition speculation. Focus on value-oriented retailers, franchise models, and premium brands including Boot Barn for western wear, Warby Parker for eyewear, and Ollie's Bargain Outlet for closeouts. Consumer behavior shifts toward lower-priced inventory are impacting performance, with mixed results across positions. Investment in cybersecurity companies like Netskope and JFrog, with JFrog being the portfolio's strongest performer rising 32% due to increased security demand following NPM supply chain attacks. Security add-on products are seeing significant pipeline growth. Position in Uranium Energy as the largest licensed uranium miner in the U.S., positioned to benefit from renewed focus on nuclear power as long-term energy solution and U.S. efforts to strengthen domestic nuclear fuel supply chains for national security. Holdings include Ceribell for portable EEG technology and Stevanato Group for pharmaceutical packaging. Ceribell surged 91% after FDA clearance for neonatal applications, while Stevanato faced conservative guidance despite beating expectations. | FROG AXGN UEC OLLI WRBY BOOT |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| Andreas Halvorsen | Viking Global Investors | $37.7B | $147.5M | 0.39% | 4,203,567 | -2,271,967 | -35.09% | 3.6159% |
| Neil Kumar | Ikarian Capital | $1.2B | $1.6M | 0.13% | 45,830 | -60,970 | -57.09% | 0.0394% |
| Lee Ainslie | Maverick Capital | $9.3B | $66.4M | 0.71% | 1,894,226 | +389,479 | +25.88% | 1.6294% |
| Mark Bussard | Rock Springs Capital | $1.9B | $19.5M | 1.01% | 557,194 | -38,735 | -6.50% | 0.4793% |
| Israel Englander | Millennium Management LLC | $233.2B | $8.9M | 0.00% | 254,596 | +240,296 | +1680.39% | 0.2190% |
| Cliff Asness | AQR Capital Management | $190.6B | $360,692 | 0.00% | 10,282 | +86 | +0.84% | 0.0088% |
| Brian Ashford-Russell | Polar Capital Holdings | $25.8B | $97.4M | 0.38% | 2,776,222 | -135,412 | -4.65% | 2.3881% |
| James E. Flynn | Deerfield Management | $6.9B | $146.1M | 2.13% | 4,164,789 | -101,904 | -2.39% | 3.5826% |
| Stanley Druckenmiller | Duquesne Capital Management | $4.5B | $107.7M | 2.40% | 3,070,146 | +1,146,446 | +59.60% | 2.6410% |
| Peter Kolchinsky | RA Capital Management | $9.8B | $335.0M | 3.43% | 9,550,191 | -588,747 | -5.81% | 8.2151% |
| Rich Handler | Jefferies | $19.3B | $420,960 | 0.00% | 12,000 | +12,000 | +100.00% | 0.0103% |